Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Targeting specific T cells may help treat alopecia areata.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Using old drugs for new uses can help treat rare immune deficiencies.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

The patient accepted her hair loss and adapted by wearing a wig and tattooing her eyebrows.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.